AVEANNA HEALTHCARE HOLDINGS (AVAH)
US05356F1057 - Common Stock
Taking everything into account, AVAH scores 2 out of 10 in our fundamental rating. AVAH was compared to 118 industry peers in the Health Care Providers & Services industry. AVAH may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, AVAH is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
AVAH had negative earnings in the past year.
In the past year AVAH had a positive cash flow from operations.
AVAH had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: AVAH reported negative operating cash flow in multiple years.
1.2 Ratios
AVAH has a worse Return On Assets (-6.92%) than 63.25% of its industry peers.
The Return On Invested Capital of AVAH (7.45%) is better than 76.07% of its industry peers.
The Average Return On Invested Capital over the past 3 years for AVAH is below the industry average of 8.65%.
The last Return On Invested Capital (7.45%) for AVAH is above the 3 year average (4.24%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.92% | ||
| ROE | N/A | ||
| ROIC | 7.45% |
ROA(3y)-17.34%
ROA(5y)-11.99%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.24%
ROIC(5y)4.05%
1.3 Margins
AVAH has a Operating Margin of 6.19%. This is in the better half of the industry: AVAH outperforms 71.79% of its industry peers.
In the last couple of years the Operating Margin of AVAH has grown nicely.
AVAH's Gross Margin of 31.10% is in line compared to the rest of the industry. AVAH outperforms 52.99% of its industry peers.
AVAH's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.19% | ||
| PM (TTM) | N/A | ||
| GM | 31.1% |
OM growth 3Y3.11%
OM growth 5Y6.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.1%
GM growth 5Y-0.02%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AVAH is destroying value.
AVAH has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, AVAH has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.37, we must say that AVAH is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.37, AVAH is doing worse than 63.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.37 |
ROIC/WACC0.79
WACC9.41%
2.3 Liquidity
A Current Ratio of 0.88 indicates that AVAH may have some problems paying its short term obligations.
With a Current ratio value of 0.88, AVAH is not doing good in the industry: 76.07% of the companies in the same industry are doing better.
AVAH has a Quick Ratio of 0.88. This is a bad value and indicates that AVAH is not financially healthy enough and could expect problems in meeting its short term obligations.
AVAH has a worse Quick ratio (0.88) than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.88 | ||
| Quick Ratio | 0.88 |
3. Growth
3.1 Past
AVAH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -25.00%.
Looking at the last year, AVAH shows a small growth in Revenue. The Revenue has grown by 6.43% in the last year.
The Revenue has been growing by 8.62% on average over the past years. This is quite good.
EPS 1Y (TTM)-25%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q40%
Revenue 1Y (TTM)6.43%
Revenue growth 3Y8.23%
Revenue growth 5Y8.62%
Revenue growth Q2Q5.2%
3.2 Future
Based on estimates for the next years, AVAH will show a very strong growth in Earnings Per Share. The EPS will grow by 35.90% on average per year.
Based on estimates for the next years, AVAH will show a small growth in Revenue. The Revenue will grow by 5.01% on average per year.
EPS Next Y28.81%
EPS Next 2Y37.23%
EPS Next 3Y35.9%
EPS Next 5YN/A
Revenue Next Year4.95%
Revenue Next 2Y5.03%
Revenue Next 3Y5.01%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
AVAH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AVAH. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
AVAH's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. AVAH is cheaper than 64.10% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 14.68 |
4.3 Compensation for Growth
AVAH's earnings are expected to grow with 35.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.23%
EPS Next 3Y35.9%
5. Dividend
5.1 Amount
No dividends for AVAH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AVEANNA HEALTHCARE HOLDINGS
NASDAQ:AVAH (5/16/2024, 3:30:01 PM)
After market: 2.65 0 (0%)2.65
-0.07 (-2.57%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap509.81M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.92% | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 6.19% | ||
| PM (TTM) | N/A | ||
| GM | 31.1% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.17
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.88 | ||
| Quick Ratio | 0.88 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-25%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y28.81%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)6.43%
Revenue growth 3Y8.23%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y